Teprenone
Chemical compound
- A02BX15 (WHO) QA02BX15 (WHO)
- In general: ℞ (Prescription only)
- (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
- 6809-52-5
- 5282199
- DB15955 Y
- 29787024
- S8S8451A4O
- D01827 Y
- CHEBI:31649
- ChEMBL79686
- DTXSID901166719
- Interactive image
- CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O
InChI
- InChI=1S/C23H38O/c1-19(2)11-7-12-20(3)13-8-14-21(4)15-9-16-22(5)17-10-18-23(6)24/h11,13,15,17H,7-10,12,14,16,18H2,1-6H3/b20-13+,21-15+,22-17+
- Key:HUCXKZBETONXFO-NJFMWZAGSA-N
Teprenone (or geranylgeranylacetone), sold under the brand name Selbex,[1] is a medication used for the treatment of gastric ulcers.[2]
References
- ^ Liu X, Jia B, Lin S (January 1996). "[Teprenone in the treatment of chronic superficial gastritis, a multicentre study]". Zhonghua Nei Ke Za Zhi (in Chinese). 35 (1): 12–4. PMID 9275638.
- ^ Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S (September 2008). "Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone". Anesth. Analg. 107 (3): 755–61. doi:10.1213/ane.0b013e31817f0e61. PMID 18713879. S2CID 19387865.
- v
- t
- e
analogues ("-prost-")
("-prazole")
acid blockers ("-prazan")
- Linaprazan
- Revaprazan
- Soraprazan
- Vonoprazan
- See also: Helicobacter pylori eradication protocols
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This article about an alkene is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e